Full article: Gutheart axis: emerging therapies targeting trimethylamine N oxide production Trimethylamine N oxide, choline and its metabolites are associated with the risk of non alcoholic fatty liver disease British Journal of Nutrition Cambridge Core The role of trimethylamine N oxide as a mediator of cardiovascular complications in chronic kidney disease Kidney International Linking anaerobic gut bacteria and cardiovascular disease Nature Microbiology Too Much TMAO is Bad for Your Health